Latest Executive Changes News

AMP Limited has appointed Blair Vernon as its new CEO, succeeding Alexis George who will retire after steering the company through major transformation. Vernon’s promotion promises continuity and a focus on growth.

Mineral Commodities Limited has made its CEO role redundant following the appointment of voluntary administrators, signalling deep restructuring ahead.

Blackstone Minerals announces the resignation of Managing Director Scott Williamson, appointing Geoff Gilmour as Executive Chairman during the search for a new CEO. The board also welcomes geologist Greg Cunnold to strengthen technical expertise amid this transition.

Chris Wright resigns as CEO of AUCyber after overseeing key restructuring, with no immediate replacement planned due to integration with 5G Networks.

James Hardie Industries has appointed Ryan Lada as its new Chief Financial Officer, succeeding Rachel Wilson who will remain as an advisor during the transition. The move comes alongside the company’s Q2 FY26 results announcement.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Deterra Royalties reported a 10% rise in quarterly revenue driven by iron ore royalties and gold offtakes, completed a US$82 million sale of non-core assets, and marked progress on the Thacker Pass lithium project amid leadership changes.

Horizon Minerals reported steady gold production from Boorara and Phillips Find, unveiled promising high-grade drilling results at Burbanks, and acquired the Gordons Project near Black Swan, while progressing a key Pre-Feasibility Study for a gold processing plant conversion.

Dundas Minerals appoints industry veteran Jonathan Downes as Managing Director, marking a strategic leadership transition following founder Shane Volk's retirement.

Assetora Limited has released its audited FY25 financial report showing a significant reduction in losses and a strengthened capital position, highlighted by the reopening of the DomaCom Fund and a $3 million private placement. The company aims to leverage these developments to accelerate growth in funds under management.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.

Synertec Corporation Limited reported an 8% revenue decline to $18.2 million in FY2025 alongside a $7.64 million net loss, yet its Engineering segment showed a strong EBITDA rebound and its Powerhouse renewable technology revenue nearly doubled.